Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case report.
1990; Wiley; Volume: 97; Issue: 11 Linguagem: Inglês
10.1111/j.1471-0528.1990.tb02484.x
ISSN1471-0528
Autores Tópico(s)Pregnancy-related medical research
ResumoBJOG: An International Journal of Obstetrics & GynaecologyVolume 97, Issue 11 p. 1061-1062 Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case report. J. J. Wiener, J. J. Wiener Department of Obstetrics and Gynaecology, University Hospital of Wales, Heath Park, CardiffSearch for more papers by this authorA. S. Evans, A. S. Evans Department of Obstetrics and Gynaecology, University Hospital of Wales, Heath Park, CardiffSearch for more papers by this author J. J. Wiener, J. J. Wiener Department of Obstetrics and Gynaecology, University Hospital of Wales, Heath Park, CardiffSearch for more papers by this authorA. S. Evans, A. S. Evans Department of Obstetrics and Gynaecology, University Hospital of Wales, Heath Park, CardiffSearch for more papers by this author First published: November 1990 https://doi.org/10.1111/j.1471-0528.1990.tb02484.xCitations: 22AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References Cameron I. T., Mitchie A. F. & Baird D. T. (1987) Prostaglandin-induccd pregnancy termination: further studies using Gemeprost (16,16 dimethyltrans Δ 2-PG El methyl ester) vaginal pessaries in the early second trimester. Prosmglandins 34, 111– 117. Duenhoelter J. H. & Gant N. F. (1975) Complications following prostaglandin F2α induced abortion. Obstet Gynecol 46, 247– 250. Lauersen N. H., Wilson K. H., Zervoudakis I. A. & Saary Z. (1976) Management of failed prostaglandin abortions. Obstet Gynecol 47, 473– 478. Lowensohn R. & Ballard Ch. A. (1974) Cervicovaginal fistula: An apparent increased incidence with prostaglandin F2α. Am J Obstet Gynecol 119, 1057– 1061. Propping D., Stubblefield P. G., Golub J. & Zuckerman J. (1977) Uterine rupture following midtrimester abortion by laminaria, prostaglandin F2α and oxytocin: report of two cases. Am J Obstet Gynecol 128, 689– 690. Sandier, R. Z., Knutzen, V. K., Milano, Ch. M. & Gleicher, N. (1979) Uterine rupture with the use of vaginal prostaglandin E2 suppositories. Am J Obstet Gynecol 134, 348– 349. Smith A. M. (1975) Rupture of uterus during prostaglandin-induced abortion. Br Med J J, 205. Vcrgote I., Oeyen L., de Schrijver D. & Uyttenbroeck F. (1982) Uterine rupture due to 15-methylprostaglandin F2α. Lancet ii, 1402. Wcntz A. C, Thompson B. H. & King T. M. (1973) Posterior cervical rupture following prostaglandininduced midtrimester abortion. Am J Obstet Gynecol 115, 1107– 1110. Citing Literature Volume97, Issue11November 1990Pages 1061-1062 ReferencesRelatedInformation
Referência(s)